Penn Pharma selected Affygility Solutions to complete the training certification based on the specific expertise offered by Affygility Solutions in potent compound safety. Affygility Solutions also offered a unique and flexible webinar format allowing Penn Pharma staff to attend from multiple global locations. The training was extremely comprehensive and included; Introduction to Potent Compound Safety, Toxicology, Industrial Hygiene, Banding and Control Strategies and the Manufacturing of Highly Potent Compounds including both understanding and controlling the risks. This comprehensive programme along with the flexibility of training made Affygility Solutions the perfect partner for Penn Pharma.
Penn Pharma Chief Operating Officer,
"This is an important component of our continued commitment to employee safety and Operational Excellence in Penn as we continue to demonstrate leadership of the handling, development and manufacturing of potent products in our contained manufacturing facility." About Penn Pharma Penn Pharma is a privately owned provider of services to the pharmaceutical and biotech industry.
Penn Pharma's services include
Penn Pharma has specialist facilities for the supply of commercial licensed products including those requiring contained operations, protecting both operators and the environment.
Penn Pharma is inspected by many authorities allowing supply of services and products to the international market (e.g. MHRA,
For more information about Penn Pharma, please visit us at www.pennpharm.com About Affygility Solutions Affygility Solutions is a leading provider of environmental, health and safety services and software to the life sciences industry. Services provided including potent compound safety program assessments, potent compound safety training, occupational exposure limits for active pharmaceutical ingredients, and containment validation. Affygility Solutions is headquartered in
Keywords for this news article include: Affygility Solutions.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Honda' s Accord Plug-in Hybrid Is a Fuel Miser
- National Retail Federation Reduces Sales Forecast
- Hernandez lawyer: Pats Records Dispute Resolved
- Social Media Startups That Pay You to Post
- Female Business Owners Still Face Gender Gap
- Amazon Fire Phone Improves on Familiar: Review
- Congress Leaving Town as Deadlines Loom
- Oregon Voters to Decide on Recreational Pot
- 4th Circuit Upholds Obamacare Subsidies
- Oregon to Vote on Recreational Marijuana